(Q43788588)

26 November 2017

title

Prediction of mortality using dobutamine echocardiography (English)

1 reference

26 November 2017

1 reference

Marwick TH

1

1 reference

26 November 2017

Case C

2

1 reference

26 November 2017

Sawada S

3

1 reference

26 November 2017

Rimmerman C

4

1 reference

26 November 2017

Brenneman P

5

1 reference

26 November 2017

Kovacs R

6

1 reference

26 November 2017

Short L

7

1 reference

26 November 2017

Lauer M

8

1 reference

26 November 2017

language of work or name

English

0 references

publication date

1 March 2001

1 reference

Journal of the American College of Cardiology

26 November 2017

published in

1 reference

26 November 2017

volume

37

1 reference

26 November 2017

issue

3

1 reference

26 November 2017

page(s)

754-760

1 reference

Stress echocardiography. Part II. Dobutamine stress echocardiography: techniques, implementation, clinical applications, and correlations

26 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2800%2901191-8

7 January 2021

Methodology, feasibility, safety and diagnostic accuracy of dobutamine stress echocardiography

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2800%2901191-8

7 January 2021

Dobutamine-atropine stress echocardiography for assessment of perioperative and late cardiac risk in patients undergoing major vascular surgery

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2800%2901191-8

7 January 2021

Improved cardiac risk stratification in major vascular surgery with dobutamine-atropine stress echocardiography

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2800%2901191-8

7 January 2021

Analysis of Probability as an Aid in the Clinical Diagnosis of Coronary-Artery Disease

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2800%2901191-8

7 January 2021

27th Bethesda Conference: matching the intensity of risk factor management with the hazard for coronary disease events. Task Force 5. Stratification of patients into high, medium and low risk subgroups for purposes of risk factor management

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2800%2901191-8

7 January 2021

Enhanced sensitivity for detection of coronary artery disease by addition of atropine to dobutamine stress echocardiography

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2800%2901191-8

7 January 2021

Prognostic value of dobutamine echocardiography in patients with high pretest likelihood of coronary artery disease

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2800%2901191-8

7 January 2021

Dobutamine stress echocardiography: sensitivity, specificity, and predictive value for future cardiac events

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2800%2901191-8

7 January 2021

Dobutamine-atropine stress echocardiography and clinical data for predicting late cardiac events in patients with suspected coronary artery disease

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2800%2901191-8

7 January 2021

Prognostic value of dobutamine stress echocardiography in patients referred because of suspected coronary artery disease

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2800%2901191-8

7 January 2021

Value of dobutamine stress echocardiography in determining the prognosis of patients with known or suspected coronary artery disease

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2800%2901191-8

7 January 2021

Comparison of the prognostic value of dipyridamole and dobutamine stress echocardiography in patients with known or suspected coronary artery disease

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2800%2901191-8

7 January 2021

Long-term prognostic significance of dobutamine echocardiography in patients with suspected coronary artery disease: results of a 5-year follow-up study.

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2800%2901191-8

7 January 2021

Role of dobutamine stress echocardiography in predicting outcome in 860 patients with known or suspected coronary artery disease

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2800%2901191-8

7 January 2021

Prognostic value of negative dobutamine stress echo in women with intermediate probability of coronary artery disease

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2800%2901191-8

7 January 2021

Prognostic value of dobutamine stress echocardiography in predicting cardiac events in patients with known or suspected coronary artery disease

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2800%2901191-8

7 January 2021

Outcome after normal exercise echocardiography and predictors of subsequent cardiac events: follow-up of 1,325 patients.

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2800%2901191-8

7 January 2021

Natural history of angina pectoris in the Framingham study. Prognosis and survival

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2800%2901191-8

7 January 2021

Value of the history and physical in identifying patients at increased risk for coronary artery disease

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2800%2901191-8

7 January 2021

The economic consequences of available diagnostic and prognostic strategies for the evaluation of stable angina patients: an observational assessment of the value of precatheterization ischemia. Economics of Noninvasive Diagnosis (END) Multicenter S

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2800%2901191-8

7 January 2021

Incremental value of prognostic testing in patients with known or suspected ischemic heart disease: a basis for optimal utilization of exercise technetium-99m sestamibi myocardial perfusion single-photon emission computed tomography

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2800%2901191-8

7 January 2021

Exercise myocardial perfusion SPECT in patients without known coronary artery disease: incremental prognostic value and use in risk stratification.

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2800%2901191-8

7 January 2021

Prognostic value of thallium-201 single-photon emission computed tomographic myocardial perfusion imaging according to extent of myocardial defect. Study in 1,926 patients with follow-up at 33 months

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2800%2901191-8

7 January 2021

Reproducibility of two-dimensional exercise echocardiography

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2800%2901191-8

7 January 2021

Analysis of interinstitutional observer agreement in interpretation of dobutamine stress echocardiograms

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2800%2901191-8

7 January 2021

The noninvasive prediction of cardiac mortality in men and women with known or suspected coronary artery disease. Economics of Noninvasive Diagnosis (END) Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2800%2901191-8

7 January 2021

Cause of death in clinical research: time for a reassessment?

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2800%2901191-8

7 January 2021

10.1016/S0735-1097(00)01191-8

Identifiers

DOI

1 reference

26 November 2017

1 reference